Inducible expression of Mad accelerates growth arrest of serum deprived human glioblastoma cells

Mad is a basic‐helix‐loop‐helix leucine zipper protein that heterodimerizes with Max. Mad: Max heterodimers recognize the same DNA binding sites as Myc: Max heterodimers. However, Myc and Mad are thought to influence transcription and cell proliferation in opposite ways through interaction with Max. While Myc activates transcription and cell proliferation Mad represses these activities (Ayer et. al., Cell 72, 211‐222, 1993). We have constructed an expression vector containing the mad cDNA cloned downstream of an inducible viral promoter. Cell lines carrying the construct were derived by transfection into human glioblastoma cells and the effect of Mad induction on their growth rate was studied. When the cells were cultured in low serum concentrations (0.1%) Mad induction resulted in accelerated growth arrest. These findings are consistent with the proposed growth repression function of the Mad protein.

[1]  D. Reisman,et al.  Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors , 1994, Molecular and cellular biology.

[2]  S Gaubatz,et al.  An E-box element localized in the first intron mediates regulation of the prothymosin alpha gene by c-myc , 1994, Molecular and cellular biology.

[3]  R. Eisenman,et al.  A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. , 1993, Genes & development.

[4]  J L Cleveland,et al.  The ornithine decarboxylase gene is a transcriptional target of c-Myc. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[5]  W. Gu,et al.  Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[6]  V. Rotter,et al.  c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[7]  R. Eisenman,et al.  Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity , 1993, Cell.

[8]  Bruno Amati,et al.  Oncogenic activity of the c-Myc protein requires dimerization with Max , 1993, Cell.

[9]  N. Hay,et al.  Sequence-specific transcriptional activation by Myc and repression by Max , 1993, Molecular and cellular biology.

[10]  G. Prendergast,et al.  Biphasic effect of Max on Myc cotransformation activity and dependence on amino- and carboxy-terminal Max functions. , 1992, Genes & development.

[11]  R. Eisenman,et al.  Myc and Max proteins possess distinct transcriptional activities , 1992, Nature.

[12]  G. Evan,et al.  Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max , 1992, Nature.

[13]  R. DePinho,et al.  Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants. , 1992, Genes & development.

[14]  B. Wold,et al.  c-myc inhibition of MyoD and myogenin-initiated myogenic differentiation , 1991, Molecular and cellular biology.

[15]  J. Bishop,et al.  The MYC protein activates transcription of the alpha‐prothymosin gene. , 1991, The EMBO journal.

[16]  E. Appella,et al.  Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[17]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[18]  M. Cole,et al.  Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment , 1986, Nature.

[19]  A. van der Eb,et al.  A new technique for the assay of infectivity of human adenovirus 5 DNA. , 1973, Virology.

[20]  R. Eisenman,et al.  Myc and Max associate in vivo. , 1992, Genes & development.

[21]  R. Eisenman,et al.  Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. , 1991, Science.

[22]  M. Cole.  The myc oncogene: its role in transformation and differentiation. , 1986, Annual review of genetics.